Traws Pharma, Inc. (TRAW) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$27.57M2012: -$22.28M2013: -$62.22M2014: -$63.74M2015: -$23.97M2016: -$23.70M2017: -$25.74M2018: -$23.28M2019: -$21.70M2020: -$24.99M2021: -$16.50M2022: -$19.63M2023: -$20.30M2024: -$142.37M2025: -$17.88M-$17.88M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$17.88M+87.4%
2024-$142.37M-601.4%
2023-$20.30M-3.4%
2022-$19.63M-19.0%
2021-$16.50M+34.0%
2020-$24.99M-15.2%
2019-$21.70M+6.8%
2018-$23.28M+9.5%
2017-$25.74M-8.6%
2016-$23.70M+1.1%
2015-$23.97M+62.4%
2014-$63.74M-2.4%
2013-$62.22M-179.3%
2012-$22.28M+19.2%
2011-$27.57M